Int J Mol Sci:特异性诱导多能干细胞在CFC患者中的成骨作用

2017-12-06 MedSci MedSci原创

心面皮肤(CFC)综合征是由细胞外信号调节激酶(ERK)通路突变引起的罕见遗传疾病。然而,关于ERK信号异常与大多数CFC综合征患者中表现出的骨发育缺陷之间的关联知之甚少。在这项研究中,从CFC综合征患者的真皮成纤维细胞中诱导性多能干细胞(iPSC)。将CFC-iPSCs分化为间充质干细胞(CFC-MSC),并在体外进一步诱导出成骨细胞。通过碱性磷酸酶活性测定,矿化测定,定量实时聚合酶链式反应(q

心面皮肤(CFC)综合征是由细胞外信号调节激酶(ERK)通路突变引起的罕见遗传疾病。然而,关于ERK信号异常与大多数CFC综合征患者中表现出的骨发育缺陷之间的关联知之甚少。

在这项研究中,从CFC综合征患者的真皮成纤维细胞中诱导性多能干细胞(iPSC)。将CFC-iPSCs分化为间充质干细胞(CFC-MSC),并在体外进一步诱导出成骨细胞。通过碱性磷酸酶活性测定,矿化测定,定量实时聚合酶链式反应(qRT-PCR)和western印迹显示CFC-MSCs的成骨缺陷。

结果显示,与野生型(WT)-MSCs相比,CFC-MSCs的成骨能力减弱。CFC-MSC在诱导成骨过程中,除了激活ERK通路,还发现p-SMAD2表达的升高和p-SMAD1表达的降低。通过抑制ERK和SMAD2信号传导或激活SMAD1通路可挽救CFC-MSC的成骨缺陷。重要的是,ERK和SMAD2信号传导的激活或SMAD1信号传导的抑制重演了WT-MSC中的成骨受损。

综上所述,该研究结果表明,SMAD2和SMAD1以及ERK通路是导致CFC综合征早期骨发育缺陷的原因,为了解该疾病的病理机制和治疗靶点提供了一个新的见解。

结果显示:

Choi JY, Han KM, et al., Impaired Osteogenesis of Disease-Specific Induced Pluripotent Stem Cells Derived from a CFC Syndrome Patient. Int J Mol Sci. 2017 Dec 1;18(12). pii: E2591. doi: 10.3390/ijms18122591.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1952927, encodeId=016c195292e34, content=<a href='/topic/show?id=2940918e65c' target=_blank style='color:#2F92EE;'>#诱导多能干细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91876, encryptionId=2940918e65c, topicName=诱导多能干细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=25d7319, createdName=珙桐, createdTime=Wed Nov 14 01:51:00 CST 2018, time=2018-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1899177, encodeId=babe18991e77c, content=<a href='/topic/show?id=6f746e94170' target=_blank style='color:#2F92EE;'>#特异性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67941, encryptionId=6f746e94170, topicName=特异性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dc7a157, createdName=jinweidong, createdTime=Tue Jun 05 21:51:00 CST 2018, time=2018-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1351641, encodeId=9e88135164137, content=<a href='/topic/show?id=e95954093cd' target=_blank style='color:#2F92EE;'>#成骨#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54093, encryptionId=e95954093cd, topicName=成骨)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Fri Dec 08 06:51:00 CST 2017, time=2017-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=267389, encodeId=32cf26e38927, content=谢谢分享谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160914/IMG57D82E721DB581755.jpg, createdBy=4fc81933929, createdName=明天会更好!, createdTime=Thu Dec 07 00:05:17 CST 2017, time=2017-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=267294, encodeId=c6a726e29421, content=间质性干细胞无所不能, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/30yrQPYKndeHChDiaiaxia9cGlrfibfht87aw13tZ9Uibdql4ibxeovoZJDoBWhQpwsuO2tL8MHicYAbI5Gsa5ic97eBGA/132, createdBy=0ddc2188194, createdName=董海鹏, createdTime=Wed Dec 06 16:56:09 CST 2017, time=2017-12-06, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1952927, encodeId=016c195292e34, content=<a href='/topic/show?id=2940918e65c' target=_blank style='color:#2F92EE;'>#诱导多能干细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91876, encryptionId=2940918e65c, topicName=诱导多能干细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=25d7319, createdName=珙桐, createdTime=Wed Nov 14 01:51:00 CST 2018, time=2018-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1899177, encodeId=babe18991e77c, content=<a href='/topic/show?id=6f746e94170' target=_blank style='color:#2F92EE;'>#特异性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67941, encryptionId=6f746e94170, topicName=特异性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dc7a157, createdName=jinweidong, createdTime=Tue Jun 05 21:51:00 CST 2018, time=2018-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1351641, encodeId=9e88135164137, content=<a href='/topic/show?id=e95954093cd' target=_blank style='color:#2F92EE;'>#成骨#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54093, encryptionId=e95954093cd, topicName=成骨)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Fri Dec 08 06:51:00 CST 2017, time=2017-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=267389, encodeId=32cf26e38927, content=谢谢分享谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160914/IMG57D82E721DB581755.jpg, createdBy=4fc81933929, createdName=明天会更好!, createdTime=Thu Dec 07 00:05:17 CST 2017, time=2017-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=267294, encodeId=c6a726e29421, content=间质性干细胞无所不能, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/30yrQPYKndeHChDiaiaxia9cGlrfibfht87aw13tZ9Uibdql4ibxeovoZJDoBWhQpwsuO2tL8MHicYAbI5Gsa5ic97eBGA/132, createdBy=0ddc2188194, createdName=董海鹏, createdTime=Wed Dec 06 16:56:09 CST 2017, time=2017-12-06, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1952927, encodeId=016c195292e34, content=<a href='/topic/show?id=2940918e65c' target=_blank style='color:#2F92EE;'>#诱导多能干细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91876, encryptionId=2940918e65c, topicName=诱导多能干细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=25d7319, createdName=珙桐, createdTime=Wed Nov 14 01:51:00 CST 2018, time=2018-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1899177, encodeId=babe18991e77c, content=<a href='/topic/show?id=6f746e94170' target=_blank style='color:#2F92EE;'>#特异性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67941, encryptionId=6f746e94170, topicName=特异性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dc7a157, createdName=jinweidong, createdTime=Tue Jun 05 21:51:00 CST 2018, time=2018-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1351641, encodeId=9e88135164137, content=<a href='/topic/show?id=e95954093cd' target=_blank style='color:#2F92EE;'>#成骨#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54093, encryptionId=e95954093cd, topicName=成骨)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Fri Dec 08 06:51:00 CST 2017, time=2017-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=267389, encodeId=32cf26e38927, content=谢谢分享谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160914/IMG57D82E721DB581755.jpg, createdBy=4fc81933929, createdName=明天会更好!, createdTime=Thu Dec 07 00:05:17 CST 2017, time=2017-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=267294, encodeId=c6a726e29421, content=间质性干细胞无所不能, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/30yrQPYKndeHChDiaiaxia9cGlrfibfht87aw13tZ9Uibdql4ibxeovoZJDoBWhQpwsuO2tL8MHicYAbI5Gsa5ic97eBGA/132, createdBy=0ddc2188194, createdName=董海鹏, createdTime=Wed Dec 06 16:56:09 CST 2017, time=2017-12-06, status=1, ipAttribution=)]
    2017-12-08 zhaojie88
  4. [GetPortalCommentsPageByObjectIdResponse(id=1952927, encodeId=016c195292e34, content=<a href='/topic/show?id=2940918e65c' target=_blank style='color:#2F92EE;'>#诱导多能干细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91876, encryptionId=2940918e65c, topicName=诱导多能干细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=25d7319, createdName=珙桐, createdTime=Wed Nov 14 01:51:00 CST 2018, time=2018-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1899177, encodeId=babe18991e77c, content=<a href='/topic/show?id=6f746e94170' target=_blank style='color:#2F92EE;'>#特异性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67941, encryptionId=6f746e94170, topicName=特异性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dc7a157, createdName=jinweidong, createdTime=Tue Jun 05 21:51:00 CST 2018, time=2018-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1351641, encodeId=9e88135164137, content=<a href='/topic/show?id=e95954093cd' target=_blank style='color:#2F92EE;'>#成骨#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54093, encryptionId=e95954093cd, topicName=成骨)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Fri Dec 08 06:51:00 CST 2017, time=2017-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=267389, encodeId=32cf26e38927, content=谢谢分享谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160914/IMG57D82E721DB581755.jpg, createdBy=4fc81933929, createdName=明天会更好!, createdTime=Thu Dec 07 00:05:17 CST 2017, time=2017-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=267294, encodeId=c6a726e29421, content=间质性干细胞无所不能, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/30yrQPYKndeHChDiaiaxia9cGlrfibfht87aw13tZ9Uibdql4ibxeovoZJDoBWhQpwsuO2tL8MHicYAbI5Gsa5ic97eBGA/132, createdBy=0ddc2188194, createdName=董海鹏, createdTime=Wed Dec 06 16:56:09 CST 2017, time=2017-12-06, status=1, ipAttribution=)]
    2017-12-07 明天会更好!

    谢谢分享谢谢分享!

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1952927, encodeId=016c195292e34, content=<a href='/topic/show?id=2940918e65c' target=_blank style='color:#2F92EE;'>#诱导多能干细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91876, encryptionId=2940918e65c, topicName=诱导多能干细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=25d7319, createdName=珙桐, createdTime=Wed Nov 14 01:51:00 CST 2018, time=2018-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1899177, encodeId=babe18991e77c, content=<a href='/topic/show?id=6f746e94170' target=_blank style='color:#2F92EE;'>#特异性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67941, encryptionId=6f746e94170, topicName=特异性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dc7a157, createdName=jinweidong, createdTime=Tue Jun 05 21:51:00 CST 2018, time=2018-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1351641, encodeId=9e88135164137, content=<a href='/topic/show?id=e95954093cd' target=_blank style='color:#2F92EE;'>#成骨#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54093, encryptionId=e95954093cd, topicName=成骨)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Fri Dec 08 06:51:00 CST 2017, time=2017-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=267389, encodeId=32cf26e38927, content=谢谢分享谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160914/IMG57D82E721DB581755.jpg, createdBy=4fc81933929, createdName=明天会更好!, createdTime=Thu Dec 07 00:05:17 CST 2017, time=2017-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=267294, encodeId=c6a726e29421, content=间质性干细胞无所不能, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/30yrQPYKndeHChDiaiaxia9cGlrfibfht87aw13tZ9Uibdql4ibxeovoZJDoBWhQpwsuO2tL8MHicYAbI5Gsa5ic97eBGA/132, createdBy=0ddc2188194, createdName=董海鹏, createdTime=Wed Dec 06 16:56:09 CST 2017, time=2017-12-06, status=1, ipAttribution=)]
    2017-12-06 董海鹏

    间质性干细胞无所不能

    0

相关资讯

Rejuvenation Res:干细胞或将为神经退行性疾病提供更佳疗法

由于大脑的自身修复和再生能力十分有限,而干细胞具有强大的分化潜能,因而被认为是针对受伤、衰老或疾病造成的大脑组织损伤或退化的最佳潜在疗法。此前,干细胞疗法已经在多项临床前研究中表现出治愈神经性疾病的希望,但在动物试验中的得到的结果与在人类患者中的并不完全一致,而表明干细胞疗法有效性的人类临床研究依然受到规模和数量的限制。近日,来自意大利巴勒莫大学的Martina Nasello及其团队回顾了已发表

STEM CELL REP:科学家发现细胞重编程新玩法

随着细胞疗法的日益发展,我们需要合适的祖细胞来源来减轻以及治疗疾病。近日,来自多伦多大学的研究人员提出了一个“中断的重编程”的策略。

72家!第二批干细胞临床研究备案机构名单公布

11月28日,国家卫计委和食药总局公布了第二批干细胞临床研究备案机构名单。

72家!第二批72个干细胞临床研究备案机构公布(含第一批和第二批机构名单)

继2016年首批30个干细胞临床研究备案机构名单公布后,时隔一年半,11月23日,食药监总局、国家卫计委联合发布第二批名单,72家三甲医院入选。

J Cell Physiol:肠道暴露了癌细胞 肠道内的干细胞可能会使癌细胞的行为更加清晰

肠的内层 - 上皮 - 不仅仅是从你的午餐中吸收营养。它随着你刚刚吃的东西而增长,缩小和调整细胞的组成。了解这一过程可能会让科学家们对癌细胞的行为有新的认识。

Kidney Int:增强干细胞在缺血再灌注肾损伤中功效的新方法!

研究表明,间充质干细胞(MSCs)对实验性缺血再灌注急性肾损伤(IRI-AKI)的治疗具有一定的效果。其中,免疫调节是MSCs治疗的重要机制之一。白细胞介素-17A(IL-17A)预处理的MSsC更具免疫抑制性,而体外免疫原性的变化很小。近期,一项发表在杂志Kidney Int上的研究旨在评估给予IL-17A-预处理的MSCs导致IRI-AKI小鼠的急性肾小管坏死评分,血清肌酐以及BUN是否显着低